NRX Pharmaceuticals Q4 EPS $(0.05) Beats $(0.07) Estimate

benzinga_article
2024.03.29 03:34

NRX Pharmaceuticals（納斯達克股票代碼：NRXP）報告每股虧損為$(0.05)，超過分析師共識預期的$(0.07)，增幅達 28.57%。與去年同期每股虧損$(0.16) 相比，虧損增長了 68.75%

NRX 製藥公司（NASDAQ 股票代碼：NRXP）報告每股虧損 0.05 美元，超過分析師預期的每股虧損 0.07 美元，增幅達 28.57%。這比去年同期每股虧損 0.16 美元增長了 68.75%

Source: benzinga_article The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.